Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Intra-Cellular Therapies, Inc. (ITCI)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| | 10-Q | | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Assets |
| Cash and equivalents | 142.3 | | 77.2 | 129.3 | 92.4 | 106.1 | 121.0 | 130.0 |
| Short-term investments | 370.6 | | 601.6 | 697.5 | 320.0 | 371.2 | 433.7 | 482.0 |
| Accounts receivable, net | 96.0 | | 47.0 | 32.8 | 20.2 | 16.9 | 15.2 | 13.7 |
| Inventories | 41.9 | | 25.0 | 7.9 | 7.9 | 8.2 | 7.8 | 7.6 |
| Other current assets | 47.4 | | 38.4 | -19.2 | 26.8 | 30.9 | 23.6 | 15.9 |
| Total current assets | 698.1 | | 789.2 | 848.3 | 467.3 | 533.2 | 601.3 | 649.1 |
| Property, plant, and equipment, net | 1.7 | | 2.1 | 2.2 | 1.8 | 1.9 | 1.8 | 1.9 |
| Long-term investments | 25.5 | | | | | | | |
| Other fixed assets | 0.1 | | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Total assets | 713.6 | | 811.9 | 868.6 | 489.9 | 557.0 | 625.7 | 674.5 |
| |
| Accounts payable | 7.7 | | 10.7 | 11.6 | 8.7 | 12.0 | 15.9 | 8.7 |
| Accrued expenses | 31.7 | | 17.3 | 12.3 | 11.1 | 16.9 | 14.1 | 13.5 |
| Short-term debt | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 52.6 | | 42.6 | 35.2 | 33.6 | 20.9 | 20.4 | 17.5 |
| Total current liabilities | 92.1 | | 70.6 | 59.1 | 53.4 | 49.9 | 50.4 | 39.7 |
| Other liabilities | 14.4 | | 19.1 | 16.8 | 18.7 | 20.3 | 21.7 | 22.6 |
| Total liabilities | 106.5 | | 89.7 | 75.8 | 72.0 | 70.2 | 72.1 | 62.3 |
| |
| Shareholders' equity [+] | 607.1 | | 722.2 | 792.8 | 417.9 | 486.8 | 553.6 | 612.1 |
| Paid-in capital | 2,173.7 | | 2,106.9 | 2,089.4 | 1,639.5 | 1,622.1 | 1,612.0 | 1,601.7 |
| Retained earnings | -1,564.3 | | -1,380.0 | -1,293.3 | -1,221.2 | -1,135.5 | -1,058.6 | -989.8 |
| Tangible shareholders' equity | 607.1 | | 722.2 | 792.8 | 417.9 | 486.8 | 553.6 | 612.1 |
|